Abnova, Antibodies and Recombinant Proteins
Abnova is the world's largest monoclonal antibody manufacturer with a capacity for generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month.
Abnova takes a genomic/proteomic approach towards antibody development, their goal being to have at least one antibody to every gene expressed in the human genome. In most cases, multiple clones are available for monoclonal antibodies. All recombinant proteins and antibodies are produced 'in house' in a state-of-the-art facility in Taiwan.
Abnova offers a unique complete monoclonal antibody and protein experience for customers that is different to traditional custom production companies and laboratories. They have an Industrial-Scale Infrastructure; maintaining a streamlined monoclonal production facility with scalable capacity for up to 500 immunizations per month, and a state-of-the-art specific pathogen free (SPF) facility, which has the breeding and holding capacity for 10,000+ mice. They also have a Wheat Germ In Vitro Protein Expression System. This is a high throughput protein production facility allowing soluble expression of conformationally correct protein, either from full-length cDNA or specific domains.
Abnova Production Technologies
Caltag Medsystems are a UK distributor of Abnova products, bringing UK based customer service and technical support to scientists within the UK and Ireland.
Information
Publications
Protocols
Resources
Literature
- Antibody Tools for Immunohistochemistry
- Antibody Tools for Immunofluorescence
- Antibody Tools for Immunoprecipitation
- Cancer Research
- ELISA and Assay Kits
- Fluorescent In Situ Hybridization (FISH)
- Immunology
- Mitochondria
- Stem Cell
- Chimera RNA Interference - a new powerful tool for mammalian gene silencing
- Custom Service for Monoclonal Antibody production
- MaxPab - a new breed of antibodies